Boehringer and Sanofi aren't the only ones chopping jobs in France. Now, Lilly says it's cutting 250 positions as it "modernizes" a…

FDA slaps Akorn with warning letter following an inspection of its sterile injectables plant in Illinois.

Mylan shelled out $9.4 million for Ascendis Health’s South African manufacturing plant that is focused on producing antiretrovirals to combat HIV.

Sun Pharma is recalling four lots of the muscle relaxant vecuronium bromide after glass fragments were found.

Fujifilm to expand its production facility in North Carolina to support increased customer needs.

Catalent plans $200 million investment to expand its drug manufacturing and drug product fill/finish at two plants.

Aurobindo issued a voluntary recall of 80 lots of valsartan tablets due to the detection of trace amounts of an impurity.

Here are some of the other stories we're following today.